Assignee
APTOSE BIOSCIENCES INC
CA·7 granted patents·5 pending applications·9 citations·filing 2013–2021
Top patents by PatentIndex Score
12 records- 0183US8987305B22,4,5-trisubstituted imidazoles and their use as anti-microbial agentsAPTOSE BIOSCIENCES INC·Filed 2013·Granted Mar 24, 2015·3 cites·57 claims
- 0280US11149047B2Aryl imidazoles for treatment of cancerAPTOSE BIOSCIENCES INC·Filed 2018·Granted Oct 19, 2021·1 cites·23 claims
- 0379US9567643B2Compositions and methods for treating cancersAPTOSE BIOSCIENCES INC·Filed 2014·Granted Feb 14, 2017·3 cites·12 claims
- 0476US10080739B2Aryl imidazoles and their use as anti-cancer agentsAPTOSE BIOSCIENCES INC·Filed 2015·Granted Sep 25, 2018·2 cites·22 claims
- 0569US11104957B2Compositions and methods for treating cancersAPTOSE BIOSCIENCES INC·Filed 2018·Granted Aug 31, 2021·0 cites·10 claims
- 0655US2021380586A12-indolyl imidazo[4,5-d]phenanthroline polymorphs and compositions regarding the sameAPTOSE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0754US9309247B22-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancerAPTOSE BIOSCIENCES INC·Filed 2014·Granted Apr 12, 2016·0 cites·27 claims
- 0854US2020171001A1Combination therapy with 2,3-dihydro-isoindole-1-one compounds and methods for treating patients with various mutationsAPTOSE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 0951US2017335400A1Compositions and methods for treating cancersAPTOSE BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 1048US2018344702A1Methods for treating patients with hematologic malignanciesAPTOSE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1141US2016176876A12-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancerAPTOSE BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 1233US11279703B2Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereofAPTOSE BIOSCIENCES INC·Filed 2017·Granted Mar 22, 2022·0 cites·10 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →